Sagar Lonial, Ho-Young Yhim, Vanesa Caruso, Jae-Cheol Jo, Sung-Hoon Jung, Youngil Koh, Peter Barth, Samineh Deheshi, Eleftheria Kalaitzaki, Brandon Kremer, Julia Boyle, Nicola Jackson, Wei Sun, Fernando Carreño, Pralay Mukhopadhyay, Joanna Opalinska, Meletios Athanasios Dimopoulos. "Design of the phase 3 DREAMM-10 study: Belantamab mafodotin plus lenalidomide and dexamethasone (BRd) vs daratumumab plus lenalidomide and dexamethasone (DRd) in transplant-ineligible, newly diagnosed multiple myeloma (TI-NDMM).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.tps7567